Diagnostics & Imaging
Eko CORE 300
Digital and analog stethoscope with amplified listening, noise cancellation, a heart-rate display and app-connected AI murmur analysis.
The Signal
The CORE 300 Digital Stethoscope's FDA record is K261694, with a substantial-equivalence decision dated July 23, 2026; Eko announced the clearance and launch on October 22, 2026. AI analysis requires pairing with the Eko app and an Eko+ membership.
Company profileMore in Diagnostics & Imaging
VisualDx
A diagnostic clinical decision support system featuring a comprehensive library of medical images.
View toolAidoc
AI platform that flags acute abnormalities in medical images to prioritize urgent patient scans.
View toolViz.ai
AI powered care coordination platform that detects strokes and other acute diseases on imaging scans.
View toolLunit
AI software that analyzes chest x rays and breast mammography scans to detect potential cancers.
View toolPaige AI
AI digital pathology platform assisting pathologists in diagnosing cancer from tissue slides and biopsies.
View tooliRhythm
Continuous cardiac monitoring service utilizing wearable biosensors and AI to detect heart arrhythmias.
View tool